In this episode of You Are an IP Company, Kary Oberbrunner and Katherine Rubino break down what they call “The IP Dam Dilemma.” As innovation accelerates in fields like biotech, AI, and 3D printing, the U.S. Patent and Trademark Office struggles to keep up—with application backlogs slowing critical progress for startups, researchers, and investors. From drug development to product launches, they explore how delays in IP protection can stall innovation, discourage investment, and leave entrepreneurs vulnerable. This is a must-listen for any creator wondering if—and when—it’s safe to go public with their big idea.